Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase Ib prophylaxis trial evaluating the safety of VIR-2482 in elderly (>65 years old) participants who will receive a flu vaccine

Next Previous
Trial Profile

A Phase Ib prophylaxis trial evaluating the safety of VIR-2482 in elderly (>65 years old) participants who will receive a flu vaccine

Status: Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs VIR 2482 (Primary)
  • Indications Influenza A virus infections
  • Focus Therapeutic Use
  • Sponsors Vir Biotechnology

Most Recent Events

  • 18 Oct 2022 According to Vir Biotechnology media release, the initial data from this study is expected in mid of F.Y. 2023.
  • 18 Oct 2022 According to Vir Biotechnology media release, the company has recently initiated this study evaluating safety of the drug in elderly participants (age 65 and older). This population will represent the company's anticipated phase III trial population.
  • 18 Oct 2022 Status changed from planning to not yet recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top